Autopsy report · NCT01939990

Safety Study of Nebivolol for COPD Patients

“Funding was discontinued.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2, Phase 3

Sponsor

University of Chicago

Sponsor type

University, hospital or other

Conditions

High Blood Pressure

Interventions

Placebo; Nebivolol

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production
  “Funding discontinued” (95% match in meaning)
• A Study of APR-246 in Oesophageal Cancer
  “Funding ceased” (87% match in meaning)
• Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy
  “no longer had funding to continue” (84% match in meaning)
• ARTerial EMbolization for haemorrhoIdal Disease (ART.EM.I. Study)
  “Funding no longer available.” (83% match in meaning)
• Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH
  “Funding was stopped” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.